Impact of Hepatitis B Virus on Inflammatory Bowel Disease
Recruiting
Observational Study
Inflammatory Bowel Disease (IBD)
Hepatitis B Virus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 162 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients.
Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection.
Participants will be subjected to history-taking (history of hosp…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female patients older than 18 years.
* Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.
Exclusion Criteria:
* Patients aged \< 18 years
* Unwilling to participate in our study
Contacts